Literature DB >> 12846736

Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.

Fumi Takemoto1, Toshimasa Shinki, Keitaro Yokoyama, Taketoshi Inokami, Shigeko Hara, Akira Yamada, Kiyoshi Kurokawa, Shunya Uchida.   

Abstract

BACKGROUND: Regulation of vitamin D hydroxylase genes in the early stage of chronic renal failure is not fully understood. Using nephrectomized rats, we examined changes in mRNA levels of CYP27B1 (25-hydroxyvitamin D3-1 alpha-hydroxylase), CYP24 (25-hydroxyvitamin D3-24-hydroxylase), and vitamin D receptor in relation to megalin, recently found to participate in renal vitamin D metabolism.
METHODS: A rat model of moderate renal failure was induced by 3/4 nephrectomy. Plasma parameters, including vitamin D metabolite concentrations, were measured at weeks 2, 4 and 8, and poly(A)+ RNA extracted from the remnant kidneys was subjected to Northern blot hybridization.
RESULTS: Plasma creatinine concentration at week 2 was 0.40 +/- 0.02 mg/dL in the sham-operated and 0.93 +/- 0.15 mg/dL in the nephrectomized rats, and both values remained constant up to week 8. Plasma concentrations of 25(OH)D3, 1 alpha,25(OH)2D3, and 24,25(OH)2D3 were unchanged between nephrectomized and sham-operated rats at week 8. Intact parathyroid hormone (PTH) increased at week 8 in nephrectomized rats. CYP27B1 mRNA in nephrectomized rats did not vary at week 2, but increased approximately two- and four-fold at weeks 4 and 8, respectively, compared to the sham-operated rats. CYP24 and megalin mRNAs, on the other hand, began to decline as early as at week 2 in nephrectomized rats and kept decreasing throughout the experiment. The expression of vitamin D receptor was modestly but significantly decreased only at week 8.
CONCLUSION: Coordinated and reciprocal alterations of the increase in CYP27B1 mRNA and the decrease in CYP24 mRNA may play a pivotal role in maintaining the plasma level of 1 alpha,25(OH)2D3 in the face of reduced nephron mass and/or megalin expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846736     DOI: 10.1046/j.1523-1755.2003.00114.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.

Authors:  Antonio Antico; Renato Tozzoli; Davide Giavarina; Elio Tonutti; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

2.  Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Authors:  Sagar U Nigwekar; Hector Tamez; Ravi I Thadhani
Journal:  Bonekey Rep       Date:  2014-02-05

3.  The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.

Authors:  Maria Vittoria Arcidiacono; Jing Yang; Elvira Fernandez; Adriana Dusso
Journal:  Nephrol Dial Transplant       Date:  2014-10-07       Impact factor: 5.992

4.  Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury.

Authors:  Chandrashekar Annamalai; Rajesh N Ganesh; Pragasam Viswanathan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-02

5.  Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.

Authors:  Daniel Zehnder; Marcus Quinkler; Kevin S Eardley; Rosemary Bland; Julia Lepenies; Susan V Hughes; Neil T Raymond; Alexander J Howie; Paul Cockwell; Paul M Stewart; Martin Hewison
Journal:  Kidney Int       Date:  2008-09-10       Impact factor: 10.612

Review 6.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

Review 7.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

8.  The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.

Authors:  Cortney R Bosworth; Gregory Levin; Cassianne Robinson-Cohen; Andrew N Hoofnagle; John Ruzinski; Bessie Young; Stephen M Schwartz; Jonathan Himmelfarb; Bryan Kestenbaum; Ian H de Boer
Journal:  Kidney Int       Date:  2012-05-30       Impact factor: 10.612

9.  Phosphorus and nutrition in chronic kidney disease.

Authors:  Emilio González-Parra; Carolina Gracia-Iguacel; Jesús Egido; Alberto Ortiz
Journal:  Int J Nephrol       Date:  2012-05-30

Review 10.  Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation.

Authors:  Adriana S Dusso
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.